|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets - Cash | |||||
| Deferred offering costs | |||||
| Current assets: | |||||
| Due from related party | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Cash and marketable securities held in Trust Account | |||||
| Total assets | |||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | |||||
| Current liabilities: | |||||
| Accrued offering costs | |||||
| Promissory note - related party | |||||
| Accounts payable and accrued expenses | |||||
| Warrant liability | |||||
| Deferred underwriting fee payable | |||||
| Total liabilities | |||||
| Class A ordinary shares subject to possible redemption, 17,250,000 shares at redemption value of $10.00 per share | |||||
| Shareholders' deficit: | |||||
| Ordinary shares, value | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total shareholders' deficit | |||||
| Total liabilities and shareholders’ deficit |
Loading...
